Finanzierung unter Führung der bestehenden Investoren Fountain Healthcare Partners und Panakès Partners. Mit den Mitteln will Neuromod die Vermarktung von Lenire in den USA und Europa vorantreiben. DUBLIN, 11. März 2025 /PRNewswire/ — Neuromod Devices Ltd. (Neuromod), ein irisches…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.